…
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates through Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses segments. It offers life, annuity, health, and accident insurance products to individuals and groups. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited operates as a subsidiary of China Life Insurance (Group) Company.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
China Life Insurance Co Ltd is a leading Chinese insurer offering life, health, pension and asset-management products through agency and bancassurance channels. Long-term growth may be supported by an aging population, rising household wealth, pension reform and digital distribution; investors may view scale, diversified product mix and an entrenched market position as advantages.
Principal risks include regulatory and policy shifts, sensitivity of investment returns to interest rates and market volatility, and intensifying competition that could pressure margins and premium growth.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 181629.00M | 115213.00M | 2147.00M | 24047.00M | 50495.00M |
| Minority interest | -2474.00M | -2005.00M | -1374.00M | -1432.00M | -1491.00M |
| Net income | 154078.00M | 106935.00M | 17266.00M | 32082.00M | 50766.00M |
| Selling general administrative | 19530.00M | 19000.00M | 43094.00M | 39874.00M | 40808.00M |
| Selling and marketing expenses | - | - | 3274.00M | 2893.00M | 2916.00M |
| Gross profit | 603327.00M | 302921.00M | 830110.00M | 803975.00M | 824526.00M |
| Reconciled depreciation | 4892.00M | 5029.00M | 4758.00M | 5291.00M | 5287.00M |
| Ebit | 181629.00M | - | -7915.00M | 13232.00M | 39402.00M |
| Ebitda | 186521.00M | - | 11582.00M | 18523.00M | 44286.00M |
| Depreciation and amortization | 4892.00M | 5029.00M | 4579.00M | 5291.00M | 4884.00M |
| Operating income | 181629.00M | 115213.00M | -7915.00M | 13232.00M | 38999.00M |
| Other operating expenses | 423485.00M | 187708.00M | 827963.00M | 779928.00M | 774031.00M |
| Interest expense | - | - | - | 4863.00M | 5598.00M |
| Tax provision | 25077.00M | 6273.00M | -16493.00M | -9467.00M | -1917.00M |
| Interest income | 124128.00M | 92523.00M | 126810.00M | - | - |
| Net interest income | - | - | - | -4863.00M | -5598.00M |
| Income tax expense | 25077.00M | 6273.00M | -16493.00M | -9467.00M | -1917.00M |
| Total revenue | 605114.00M | 302921.00M | 830110.00M | 803975.00M | 824526.00M |
| Total operating expenses | 421698.00M | 187708.00M | 827963.00M | -790743.00M | -785527.00M |
| Cost of revenue | 1787.00M | - | -89209.00M | - | - |
| Total other income expense net | 11439.00M | 115213.00M | 8688.00M | 10815.00M | 11341.00M |
| Net income from continuing ops | 156552.00M | 108940.00M | 18640.00M | 33514.00M | 52412.00M |
| Net income applicable to common shares | - | - | - | - | 50921.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 7591004.00M | 6769546.00M | 5888479.00M | 5251988.00M | 4891085.00M |
| Intangible assets | 8090.00M | 8262.00M | 8369.00M | 8092.00M | 8011.00M |
| Other current assets | - | -86519.00M | 681564.00M | - | 59048.00M |
| Total liab | 6982611.00M | 6248298.00M | 5418437.00M | 4806867.00M | 4404427.00M |
| Total stockholder equity | 595205.00M | 509675.00M | 460110.00M | 436169.00M | 478585.00M |
| Deferred long term liab | - | - | - | - | 822.00M |
| Other current liab | 6373489.00M | -1682.00M | -68446.00M | -60819.00M | -56818.00M |
| Common stock | 28265.00M | 28265.00M | 28265.00M | 28265.00M | 28265.00M |
| Capital stock | 28265.00M | 28265.00M | 28265.00M | 28265.00M | 28265.00M |
| Retained earnings | 485603.00M | 362377.00M | 366524.00M | 201688.00M | 201265.00M |
| Other liab | - | - | - | - | 3708174.00M |
| Other assets | - | 6769546.00M | -6825506.00M | -495153.00M | -111694.00M |
| Cash | 143319.00M | 86519.00M | 149566.00M | 127594.00M | 60440.00M |
| Total current liabilities | 6424347.00M | - | 509548.00M | 60819.00M | 56818.00M |
| Current deferred revenue | 48227.00M | - | 49836.00M | - | 55342.00M |
| Net debt | -106529.00M | -37249.00M | -100593.00M | -78254.00M | -4578.00M |
| Short term debt | 6.00M | 65.00M | 217461.00M | - | 1476.00M |
| Short long term debt | 6.00M | 65.00M | - | - | 1476.00M |
| Short long term debt total | 36790.00M | 49270.00M | 48973.00M | 49340.00M | 55862.00M |
| Other stockholder equity | 81337.00M | 119033.00M | 53934.00M | 48627.00M | 50299.00M |
| Property plant equipment | - | - | - | 55887.00M | 56154.00M |
| Total current assets | 143319.00M | - | 2412613.00M | 1885399.00M | 1510088.00M |
| Long term investments | 6792986.00M | 6037641.00M | 4480973.00M | 3797281.00M | 3427764.00M |
| Net tangible assets | - | - | - | - | 470176.00M |
| Short term investments | - | - | 2263047.00M | 1738108.00M | 1429287.00M |
| Net receivables | - | - | 29494.00M | 19697.00M | 20361.00M |
| Long term debt | 35245.00M | 47887.00M | 47718.00M | 47771.00M | 53680.00M |
| Accounts payable | - | - | 67340.00M | 60819.00M | 56818.00M |
| Accumulated other comprehensive income | - | - | 11387.00M | 206216.00M | 249055.00M |
| Non currrent assets other | 7042930.00M | -6141150.00M | -4579174.00M | -22307.00M | -121.00M |
| Non current assets total | 7447685.00M | - | 10301372.00M | 3861742.00M | 3492691.00M |
| Capital lease obligations | 1539.00M | 1318.00M | 1255.00M | 1569.00M | 2182.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -565796.00M | -354620.00M | -422930.00M | -164955.00M | -492242.00M |
| Change to liabilities | - | - | - | -11657.00M | -6741.00M |
| Total cashflows from investing activities | -547368.00M | - | - | -164955.00M | -393731.00M |
| Net borrowings | -12812.00M | - | - | -98298.00M | 115694.00M |
| Total cash from financing activities | 144341.00M | -86759.00M | 60273.00M | -120095.00M | 111139.00M |
| Change to operating activities | - | - | - | 67460.00M | 22026.00M |
| Net income | 156552.00M | 108940.00M | 21110.00M | 24047.00M | 50495.00M |
| Change in cash | 56868.00M | -62556.00M | 20467.00M | 67135.00M | 3785.00M |
| Begin period cash flow | 85505.00M | 148061.00M | 127594.00M | 60459.00M | 56655.00M |
| End period cash flow | 142373.00M | 85505.00M | 148061.00M | 127594.00M | 60440.00M |
| Total cash from operating activities | 459925.00M | 378795.00M | 388232.00M | 351968.00M | 286448.00M |
| Depreciation | 4892.00M | 5029.00M | 4758.00M | 5291.00M | 5287.00M |
| Other cashflows from investing activities | -21778.00M | -8156.00M | 158149.00M | 186635.00M | 174488.00M |
| Dividends paid | 26602.00M | 26915.00M | 22189.00M | 18372.00M | 18089.00M |
| Change to account receivables | -599.00M | 24.00M | 3539.00M | 10466.00M | 3604.00M |
| Sale purchase of stock | - | - | - | 0.00M | 0.00M |
| Other cashflows from financing activities | 183755.00M | -59771.00M | 84145.00M | -92141.00M | 130745.00M |
| Change to netincome | - | - | - | 283612.00M | 255878.00M |
| Capital expenditures | 3056.00M | 3979.00M | 4171.00M | 3076.00M | 5475.00M |
| Change in working capital | 13093.00M | -15954.00M | 94132.00M | 43155.00M | 1124.00M |
| Other non cash items | 285388.00M | 280780.00M | 268232.00M | 279475.00M | 229542.00M |
| Free cash flow | 456869.00M | 374816.00M | 384061.00M | 348892.00M | 280973.00M |
Sector: Financial Services Industry: Insurance - Life
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| CILJF China Life Insurance Co Ltd |
0.19 5.81% |
3.46 | 2.96 | 5.06 | 0.23 | 1.11 | 1.10 |
| PIAIF Ping An Insurance |
- -% |
5.96 | 5.78 | 5.15 | 0.13 | 0.85 | 1.31 |
| AAGIY AIA Group Ltd ADR |
-0.21 0.52% |
40.11 | 12.84 | 11.34 | 3.88 | 2.47 | 2.22 |
| AAIGF AIA Group Ltd |
-0.16 1.59% |
9.90 | 12.45 | 10.93 | 3.86 | 2.38 | 2.21 |
| PNGAY Ping An Insurance Company of China |
0.04 0.30% |
13.49 | 6.93 | 3.57 | 0.07 | 0.59 | 0.17 |
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates through Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses segments. It offers life, annuity, health, and accident insurance products to individuals and groups. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited operates as a subsidiary of China Life Insurance (Group) Company.
| Name | Title | Year Born |
|---|---|---|
| Ms. Hong Yang | VP, Operating Director & GM of the Operation Service Center | 1967 |
| Ms. Di Zhang | Assistant to the Pres & Chief Investment Officer | 1968 |
| Mr. Ruan Qi | VP | 1966 |
| Mr. Chongmiao Xu | Compliance Officer, GM of the Legal & Compliance Department and Legal Officer | 1969 |
| Mr. Zhong Zhan | VP, Marketing Director & GM of Individual Insurance Division | 1968 |
| Mr. Mingguang Li | Chief Actuary, VP, Board Sec. & Exec. Director | 1969 |
| Mr. Guodong Zhao | Assistant to the Pres | 1967 |
| Mr. Yuejin Liu | Assistant to the Pres | 1967 |
| Dr. Tao Bai Ph.D. | Exec. Chairman | 1963 |
| Mr. Peng Zhao | Exec. Director | 1973 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.